CN Stock MarketDetailed Quotes

688139 Qingdao Haier Biomedical Co., Ltd.

Watchlist
  • 34.90
  • +5.27+17.79%
Market Closed Sep 30 15:00 CST
11.10BMarket Cap30.67P/E (TTM)

Qingdao Haier Biomedical Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-3.71%1.22B
0.04%686.91M
-20.36%2.28B
-12.00%1.83B
0.20%1.27B
21.87%686.67M
34.72%2.86B
36.52%2.08B
36.63%1.27B
36.22%563.45M
Operating revenue
-3.71%1.22B
0.04%686.91M
-20.36%2.28B
-12.00%1.83B
0.20%1.27B
21.87%686.67M
34.72%2.86B
36.52%2.08B
36.63%1.27B
36.22%563.45M
Total operating cost
-5.39%979.18M
-3.33%538.74M
-14.23%1.97B
-6.87%1.53B
5.84%1.03B
20.72%557.27M
35.84%2.29B
37.09%1.64B
38.19%977.88M
41.28%461.61M
Operating cost
-0.56%632.77M
2.93%346.21M
-24.17%1.13B
-18.08%897.46M
2.17%636.34M
20.67%336.35M
40.10%1.48B
46.09%1.1B
35.86%622.8M
35.37%278.74M
Operating tax surcharges
-4.94%11.11M
-3.53%5.76M
-7.90%20.81M
-3.36%15.62M
22.04%11.68M
23.39%5.97M
41.05%22.6M
31.99%16.16M
34.10%9.57M
19.83%4.84M
Operating expense
-6.81%136.3M
0.14%80.48M
-2.53%339.57M
5.53%251.8M
-7.26%146.26M
1.29%80.36M
32.81%348.37M
27.15%238.61M
56.74%157.71M
38.44%79.34M
Administration expense
-10.56%83.82M
-9.93%41.04M
10.95%183.47M
20.30%135.91M
28.57%93.72M
35.38%45.57M
31.53%165.35M
32.95%112.97M
29.28%72.89M
22.29%33.66M
Financial expense
-165.97%-28.27M
-233.31%-12M
-16.04%-23.53M
55.31%-14.89M
43.96%-10.63M
400.30%9M
-70.67%-20.28M
-187.28%-33.33M
-153.23%-18.97M
68.06%-3M
-Interest expense (Financial expense)
-6.36%1.76M
-5.12%842.63K
30.79%3.51M
51.37%2.85M
43.69%1.88M
35.56%888.12K
-7.16%2.69M
-16.86%1.88M
-20.35%1.31M
112.22%655.16K
-Interest Income (Financial expense)
-93.90%-28.27M
-92.47%-13.04M
-75.42%-35.61M
-54.94%-23.94M
-48.49%-14.58M
-37.38%-6.77M
-90.02%-20.3M
-102.51%-15.45M
-113.22%-9.82M
-195.22%-4.93M
Research and development
-8.96%143.45M
-3.44%77.26M
9.63%320.64M
14.87%242.65M
17.71%157.57M
17.62%80.01M
23.77%292.47M
21.40%211.25M
44.61%133.87M
64.55%68.02M
Credit Impairment Loss
-3,491.89%-15.49M
-14,151.72%-6.73M
-116.73%-2.42M
-223.37%-993.68K
-1,398.09%-431.24K
154.00%47.88K
-128.88%-1.12M
444.54%805.42K
-96.83%33.22K
104.39%18.85K
Asset Impairment Loss
-13.67%-1.73M
-102.29%-12.5K
69.64%-1.64M
34.34%-1.46M
39.43%-1.52M
174.90%545.75K
-307.43%-5.41M
-358.74%-2.22M
-544.18%-2.51M
-2,536.08%-728.65K
Other net revenue
Fair value change income
-178.04%-1.14M
4.79%334.52K
129.33%2.06M
34.50%-4.13M
118.14%1.46M
103.65%319.23K
-168.64%-7.01M
-208.58%-6.3M
-154.07%-8.05M
-191.35%-8.75M
Invest income
-80.55%11.31M
-74.71%3.29M
11.12%83.03M
30.56%73.35M
48.63%58.13M
-40.90%13.02M
-84.21%74.72M
-86.88%56.18M
-90.27%39.11M
-94.16%22.02M
-Including: Investment income associates
39.48%2.88M
129.18%995.59K
-8.82%8.17M
-29.29%3.9M
-18.00%2.07M
-23.81%434.42K
-36.85%8.96M
-49.40%5.52M
-74.84%2.52M
-90.65%570.16K
Asset deal income
93.69%-130.26K
---81.51K
-411.31%-1.6M
-446.99%-2.06M
-31,509.08%-2.06M
----
---312.75K
--594.48K
--6.57K
--881.17
Other revenue
-5.13%19.87M
16.07%9.3M
1.94%45.01M
4.14%32.68M
49.30%20.94M
-8.59%8.01M
16.58%44.16M
3.48%31.38M
232.66%14.03M
186.54%8.77M
Operating profit
-17.70%256.79M
1.94%154.28M
-35.12%438.4M
-23.19%395.18M
-6.19%312.02M
22.86%151.34M
-29.72%675.68M
-34.60%514.46M
-48.21%332.62M
-74.15%123.18M
Add:Non operating Income
60.05%2.1M
-34.18%446.14K
6.59%3.34M
37.28%2.51M
-10.81%1.31M
-39.34%677.84K
-0.61%3.14M
-28.20%1.83M
-13.41%1.47M
106.79%1.12M
Less:Non operating expense
-99.72%17.28K
-20.40%21.41K
108.43%7.25M
3,060.61%6.07M
4,015.28%6.07M
-51.70%26.9K
-6.40%3.48M
-91.60%192.05K
-90.39%147.48K
-71.84%55.69K
Total profit
-15.75%258.87M
1.78%154.7M
-35.66%434.49M
-24.12%391.62M
-7.99%307.27M
22.34%151.99M
-29.72%675.34M
-34.41%516.1M
-48.02%333.94M
-73.95%124.24M
Less:Income tax cost
-14.41%19.73M
2.93%12.85M
-64.60%22.43M
-49.61%25.98M
-27.20%23.05M
21.11%12.48M
-43.28%63.36M
-40.34%51.55M
-53.46%31.67M
-81.81%10.31M
Net profit
-15.86%239.14M
1.68%141.85M
-32.67%412.06M
-21.29%365.65M
-5.97%284.21M
22.45%139.51M
-27.93%611.97M
-33.68%464.54M
-47.37%302.27M
-72.89%113.93M
Net profit from continuing operation
-15.86%239.14M
1.68%141.85M
-32.67%412.06M
-21.29%365.65M
-5.97%284.21M
22.45%139.51M
-27.93%611.97M
-33.68%464.54M
-47.37%302.27M
-72.89%113.93M
Less:Minority Profit
-16.60%4.79M
114.58%4.24M
-46.48%5.99M
172.66%8.44M
238.25%5.75M
383.74%1.97M
170.44%11.18M
36.96%3.1M
31.09%1.7M
17.26%408.23K
Net profit of parent company owners
-15.84%234.34M
0.06%137.61M
-32.41%406.07M
-22.59%357.2M
-7.36%278.46M
21.15%137.54M
-28.90%600.79M
-33.91%461.45M
-47.55%300.57M
-72.96%113.52M
Earning per share
Basic earning per share
-15.91%0.74
2.33%0.44
-32.28%1.28
-22.60%1.13
-7.37%0.88
19.44%0.43
-29.21%1.89
-33.64%1.46
-47.51%0.95
-72.73%0.36
Diluted earning per share
-15.91%0.74
2.33%0.44
-32.28%1.28
-22.60%1.13
-7.37%0.88
19.44%0.43
-28.95%1.89
-33.64%1.46
-47.51%0.95
-72.73%0.36
Other composite income
18.43%-24.45M
-86.99%12.75K
-42.97%-43.52M
-1,478.03%-30.52M
-1,395.84%-29.98M
175.66%98.06K
-135.67%-30.44M
-90.95%2.21M
-90.59%2.31M
-113.49%-129.61K
Other composite income of parent company owners
18.43%-24.45M
-86.99%12.75K
-42.97%-43.52M
-1,478.03%-30.52M
-1,395.84%-29.98M
175.66%98.06K
-135.67%-30.44M
-90.95%2.21M
-90.59%2.31M
-113.49%-129.61K
Total composite income
-15.56%214.69M
1.62%141.86M
-36.63%368.54M
-28.20%335.13M
-16.53%254.23M
22.68%139.61M
-37.77%581.53M
-35.61%466.76M
-49.15%304.58M
-72.98%113.8M
Total composite income of parent company owners
-15.53%209.89M
-0.00%137.63M
-36.43%362.55M
-29.54%326.69M
-17.96%248.48M
21.38%137.63M
-38.70%570.35M
-35.84%463.66M
-49.32%302.88M
-73.05%113.39M
Total composite income of minority owners
-16.60%4.79M
114.58%4.24M
-46.48%5.99M
172.66%8.44M
238.25%5.75M
383.74%1.97M
170.44%11.18M
36.96%3.1M
31.09%1.7M
17.26%408.23K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -3.71%1.22B0.04%686.91M-20.36%2.28B-12.00%1.83B0.20%1.27B21.87%686.67M34.72%2.86B36.52%2.08B36.63%1.27B36.22%563.45M
Operating revenue -3.71%1.22B0.04%686.91M-20.36%2.28B-12.00%1.83B0.20%1.27B21.87%686.67M34.72%2.86B36.52%2.08B36.63%1.27B36.22%563.45M
Total operating cost -5.39%979.18M-3.33%538.74M-14.23%1.97B-6.87%1.53B5.84%1.03B20.72%557.27M35.84%2.29B37.09%1.64B38.19%977.88M41.28%461.61M
Operating cost -0.56%632.77M2.93%346.21M-24.17%1.13B-18.08%897.46M2.17%636.34M20.67%336.35M40.10%1.48B46.09%1.1B35.86%622.8M35.37%278.74M
Operating tax surcharges -4.94%11.11M-3.53%5.76M-7.90%20.81M-3.36%15.62M22.04%11.68M23.39%5.97M41.05%22.6M31.99%16.16M34.10%9.57M19.83%4.84M
Operating expense -6.81%136.3M0.14%80.48M-2.53%339.57M5.53%251.8M-7.26%146.26M1.29%80.36M32.81%348.37M27.15%238.61M56.74%157.71M38.44%79.34M
Administration expense -10.56%83.82M-9.93%41.04M10.95%183.47M20.30%135.91M28.57%93.72M35.38%45.57M31.53%165.35M32.95%112.97M29.28%72.89M22.29%33.66M
Financial expense -165.97%-28.27M-233.31%-12M-16.04%-23.53M55.31%-14.89M43.96%-10.63M400.30%9M-70.67%-20.28M-187.28%-33.33M-153.23%-18.97M68.06%-3M
-Interest expense (Financial expense) -6.36%1.76M-5.12%842.63K30.79%3.51M51.37%2.85M43.69%1.88M35.56%888.12K-7.16%2.69M-16.86%1.88M-20.35%1.31M112.22%655.16K
-Interest Income (Financial expense) -93.90%-28.27M-92.47%-13.04M-75.42%-35.61M-54.94%-23.94M-48.49%-14.58M-37.38%-6.77M-90.02%-20.3M-102.51%-15.45M-113.22%-9.82M-195.22%-4.93M
Research and development -8.96%143.45M-3.44%77.26M9.63%320.64M14.87%242.65M17.71%157.57M17.62%80.01M23.77%292.47M21.40%211.25M44.61%133.87M64.55%68.02M
Credit Impairment Loss -3,491.89%-15.49M-14,151.72%-6.73M-116.73%-2.42M-223.37%-993.68K-1,398.09%-431.24K154.00%47.88K-128.88%-1.12M444.54%805.42K-96.83%33.22K104.39%18.85K
Asset Impairment Loss -13.67%-1.73M-102.29%-12.5K69.64%-1.64M34.34%-1.46M39.43%-1.52M174.90%545.75K-307.43%-5.41M-358.74%-2.22M-544.18%-2.51M-2,536.08%-728.65K
Other net revenue
Fair value change income -178.04%-1.14M4.79%334.52K129.33%2.06M34.50%-4.13M118.14%1.46M103.65%319.23K-168.64%-7.01M-208.58%-6.3M-154.07%-8.05M-191.35%-8.75M
Invest income -80.55%11.31M-74.71%3.29M11.12%83.03M30.56%73.35M48.63%58.13M-40.90%13.02M-84.21%74.72M-86.88%56.18M-90.27%39.11M-94.16%22.02M
-Including: Investment income associates 39.48%2.88M129.18%995.59K-8.82%8.17M-29.29%3.9M-18.00%2.07M-23.81%434.42K-36.85%8.96M-49.40%5.52M-74.84%2.52M-90.65%570.16K
Asset deal income 93.69%-130.26K---81.51K-411.31%-1.6M-446.99%-2.06M-31,509.08%-2.06M-------312.75K--594.48K--6.57K--881.17
Other revenue -5.13%19.87M16.07%9.3M1.94%45.01M4.14%32.68M49.30%20.94M-8.59%8.01M16.58%44.16M3.48%31.38M232.66%14.03M186.54%8.77M
Operating profit -17.70%256.79M1.94%154.28M-35.12%438.4M-23.19%395.18M-6.19%312.02M22.86%151.34M-29.72%675.68M-34.60%514.46M-48.21%332.62M-74.15%123.18M
Add:Non operating Income 60.05%2.1M-34.18%446.14K6.59%3.34M37.28%2.51M-10.81%1.31M-39.34%677.84K-0.61%3.14M-28.20%1.83M-13.41%1.47M106.79%1.12M
Less:Non operating expense -99.72%17.28K-20.40%21.41K108.43%7.25M3,060.61%6.07M4,015.28%6.07M-51.70%26.9K-6.40%3.48M-91.60%192.05K-90.39%147.48K-71.84%55.69K
Total profit -15.75%258.87M1.78%154.7M-35.66%434.49M-24.12%391.62M-7.99%307.27M22.34%151.99M-29.72%675.34M-34.41%516.1M-48.02%333.94M-73.95%124.24M
Less:Income tax cost -14.41%19.73M2.93%12.85M-64.60%22.43M-49.61%25.98M-27.20%23.05M21.11%12.48M-43.28%63.36M-40.34%51.55M-53.46%31.67M-81.81%10.31M
Net profit -15.86%239.14M1.68%141.85M-32.67%412.06M-21.29%365.65M-5.97%284.21M22.45%139.51M-27.93%611.97M-33.68%464.54M-47.37%302.27M-72.89%113.93M
Net profit from continuing operation -15.86%239.14M1.68%141.85M-32.67%412.06M-21.29%365.65M-5.97%284.21M22.45%139.51M-27.93%611.97M-33.68%464.54M-47.37%302.27M-72.89%113.93M
Less:Minority Profit -16.60%4.79M114.58%4.24M-46.48%5.99M172.66%8.44M238.25%5.75M383.74%1.97M170.44%11.18M36.96%3.1M31.09%1.7M17.26%408.23K
Net profit of parent company owners -15.84%234.34M0.06%137.61M-32.41%406.07M-22.59%357.2M-7.36%278.46M21.15%137.54M-28.90%600.79M-33.91%461.45M-47.55%300.57M-72.96%113.52M
Earning per share
Basic earning per share -15.91%0.742.33%0.44-32.28%1.28-22.60%1.13-7.37%0.8819.44%0.43-29.21%1.89-33.64%1.46-47.51%0.95-72.73%0.36
Diluted earning per share -15.91%0.742.33%0.44-32.28%1.28-22.60%1.13-7.37%0.8819.44%0.43-28.95%1.89-33.64%1.46-47.51%0.95-72.73%0.36
Other composite income 18.43%-24.45M-86.99%12.75K-42.97%-43.52M-1,478.03%-30.52M-1,395.84%-29.98M175.66%98.06K-135.67%-30.44M-90.95%2.21M-90.59%2.31M-113.49%-129.61K
Other composite income of parent company owners 18.43%-24.45M-86.99%12.75K-42.97%-43.52M-1,478.03%-30.52M-1,395.84%-29.98M175.66%98.06K-135.67%-30.44M-90.95%2.21M-90.59%2.31M-113.49%-129.61K
Total composite income -15.56%214.69M1.62%141.86M-36.63%368.54M-28.20%335.13M-16.53%254.23M22.68%139.61M-37.77%581.53M-35.61%466.76M-49.15%304.58M-72.98%113.8M
Total composite income of parent company owners -15.53%209.89M-0.00%137.63M-36.43%362.55M-29.54%326.69M-17.96%248.48M21.38%137.63M-38.70%570.35M-35.84%463.66M-49.32%302.88M-73.05%113.39M
Total composite income of minority owners -16.60%4.79M114.58%4.24M-46.48%5.99M172.66%8.44M238.25%5.75M383.74%1.97M170.44%11.18M36.96%3.1M31.09%1.7M17.26%408.23K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data